# Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment

> **NCT02101190** · PHASE1 · COMPLETED · sponsor: **Bial - Portela C S.A.** · enrollment: 16 (actual)

## Conditions studied

- Parkinson's Disease

## Interventions

- **DRUG:** BIA 9-1067

## Key facts

- **NCT ID:** NCT02101190
- **Lead sponsor:** Bial - Portela C S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-03
- **Primary completion:** 2010-05
- **Final completion:** 2010-05
- **Target enrollment:** 16 (ACTUAL)
- **Last updated:** 2015-01-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02101190

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02101190, "Pharmacokinetics of BIA 9-1067 in Subjects With Hepatic Impairment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02101190. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*